+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Drugs By Therapeutic Area Market Research Reports

From
From
From
Osteogenesis Imperfecta (OI) - Epidemiology Forecast - 2034 - Product Thumbnail Image

Osteogenesis Imperfecta (OI) - Epidemiology Forecast - 2034

  • Report
  • August 2024
  • 57 Pages
  • Global
From
Dermatomyositis - Epidemiology Forecast - 2034 - Product Thumbnail Image

Dermatomyositis - Epidemiology Forecast - 2034

  • Report
  • August 2024
  • 110 Pages
  • Global
From
From
From
From
From
Mucopolysaccharidosis Type I - Pipeline Insight, 2024 - Product Thumbnail Image

Mucopolysaccharidosis Type I - Pipeline Insight, 2024

  • Drug Pipelines
  • July 2024
  • 60 Pages
  • Global
From
From
From
From
Tendinopathy - Pipeline Insight, 2024 - Product Thumbnail Image

Tendinopathy - Pipeline Insight, 2024

  • Drug Pipelines
  • July 2024
  • 60 Pages
  • Global
From
From
From
From
From
From
From
Loading Indicator

The Drugs by Therapeutic Area market is a segment of the pharmaceutical industry that focuses on the development and sale of drugs for specific medical conditions. These drugs are designed to treat a wide range of diseases, from cancer to mental health disorders. Companies in this market typically specialize in one or more therapeutic areas, such as oncology, neurology, or cardiology. They develop drugs that target specific medical conditions and then market them to healthcare providers and patients. Companies in this market include Pfizer, Merck, Novartis, GlaxoSmithKline, and Sanofi. Show Less Read more